19 Current news of Applera
rssBiotech Innovators Will Contribute to International Effort To Produce Most Detailed Map of Genetic Variation
06-13-2008
Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: ...
05-26-2008
Applera and BIOTECON Diagnostics (BCD) announced a non-exclusive, worldwide license agreement relating to PCR technology for Food Testing Applications and Genetically-Modified Organism (GMO) Testing Applications: BIOTECON Diagnostics has acquired important rights with the PCR licence. In ...
02-25-2008
Lab21 announced that it has obtained a licence from Celera, an Applera Corporation business, to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland. The test, known as CRS7, is the first clinical test capable of ...
02-11-2008
Enigma Diagnostics announced that it has signed license agreements with Applera Corporation. The licenses, signed 6 February 2008, include a Real-Time Instrument Patent License Agreement and an Application Kit License Agreement. These agreements provide Enigma with access under patents owned ...
Researchers collaborate with Applied Biosystems to validate specific genetic polymorphisms for identifying individual pigs from commercial breeds
12-11-2007
Scientists at the Universitat Autònoma de Barcelona, Spain, have developed and validated an identity test that can be used to confirm the breed and origin of meat from farm animals. The test was developed in collaboration with Applied Biosystems , an Applera Corporation business, and uses a ...
Researchers in the Netherlands use new technology from Applied Biosystems to identify different expression patterns of microRNA molecules in normal and cancerous cells
10-18-2007
Scientists at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems, an Applera Corporation business, have made significant advances in testicular cancer research by identifying and analyzing a set of specific microRNA molecular markers that are ...
Parties Could Not Agree on Further Development and Commercialization
06-06-2007
Applied Biosystems, an Applera Corporation business, announced that its contract with the U.S. Department of Defense surrounding the development of a prototype instrument system to improve the way infectious diseases are identified for epidemiological and biosecurity purposes has been ...
11-21-2006
Enzo Biochem, Inc. announced that the United States Patent and Trademark Office has declared a patent interference between an allowed patent application of its subsidiary, Enzo Life Sciences, Inc., and a patent held by California Institute of Technology ("Cal Tech") and licensed exclusively ...
Alzheimer's Disease, Parkinson's Disease and Dementia with Lewy Bodies Targeted in Protein Study Enabled by Applied Biosystems/MDS SCIEX's Advanced Technologies
08-25-2006
Applied Biosystems, an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc., announced the outcome of the scientific research community's most extensive, spinal fluid-based protein study on neurodegenerative diseases to date. Researchers from the ...
08-24-2006
Celera Genomics, an Applera Corporation business, announced that the National Institutes of Health (NIH) has awarded Celera approximately $900,000 to develop and commercialize an in vitro diagnostic (IVD) test for the highly pathogenic influenza A/H5 virus (Asian lineage, H5N1). The test ...
